Titanium Healthcare's ROE per quarter

Return on Equity, Quarterly Results, Trends, Rankings, Statistics

What is ROE for Titanium Healthcare in the third quarter 2015?
Due to the lack of equity, it was not possible to calculate Titanium Healthcare, Inc.'s return on equity (ROE) in its third quarter 2015

What is ROE?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Equity ROE▼

None ▼

Return on Equity ROE▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Equity	(Sep 30 2015) III. Quarter	(Jun 30 2015) II. Quarter	(Mar 31 2015) I. Quarter	(Dec 31 2014) IV. Quarter	(Sep 30 2014) III. Quarter
Y / Y Equity Change	-	-	-	-	-
Y / Y Net Income Change	-	-	-	-	-
Net Income (TTM) in Millions	-3	-3	-3	-2	-2
Return On Equity (TTM)	-	-	-	-	-
TIHC's Total Ranking	#	#	#	#	#
Equity (TTM) in Millions	-2	-2	-1	-1	-1
Seq. Equity Change	-	-	-	-	-
Seq. Net Income Change	-	-	-	-	-

Back to TIHC Management Effectiveness >> TIHC's 5 Years Annual ROE >> Compare TIHC ROE to its Competitors

Return On Equity Company Ranking
Within:	No.
Industry	#
Sector	#
Overall	#

Return On Equity Statistics
High	Average	Low
0 %	0 %	0 %

TIHC Annual Return On Equity	(Dec 31 2014) 2014	(Dec 31 2013) 2013	(Dec 31 2012) 2012	(Dec 31 2010) 2011
Total Equity in Millions	-1	0	0	0	0
Y / Y Equity Change	-	-	-96.28 %	-	-
Net Income in Millions	-2	0	0	0	0
Y / Y Net Income Change	-	-	-	-	-
Return On Equity	-	-	-3900.28 %	-634.74 %	-

Back to TIHC Management Effectiveness >> TIHC's 5 Years Annual ROE >> Compare TIHC ROE to its Competitors

More Return On Equity Ratios
Medical Laboratories Industry Roe Trends and Statistics
Healthcare Sector Return On Equity Statistics
TIHC's' Return on Equity at Yahoo Finance
TIHC's Roe Ratio versus Medical Laboratories Industry, Healthcare Sector and overall Market
Highest Ranking Return On Equity
Lowest Ranking Return On Equity
Subscribers only: Roe for TIHC's Competitors
Subscribers only: Roe for Titanium Healthcare's Suppliers
Subscribers only: Return On Equity for TIHC's Customers

Companies with similar Return On Equity at Sep 30 2015, within Healthcare Sector	ROE
Relmada Therapeutics Inc	255.70 %
Phibro Animal Health Corporation	246.85 %
Armata Pharmaceuticals Inc	234.72 %
Ligand Pharmaceuticals Incorporated	232.76 %
Fennec Pharmaceuticals Inc	142.18 %
Adm Tronics Unlimited Inc	137.68 %
Fonar Corporation	107.77 %
Lifevantage Corp	101.10 %
Gilead Sciences Inc	99.33 %
Radnet Inc	88.50 %
Abbvie Inc	83.55 %
Travere Therapeutics Inc	63.29 %
Star Equity Holdings Inc	59.89 %
Viskase Holdings inc	58.89 %
United Therapeutics Corporation	56.69 %
Mettler toledo International Inc	53.40 %
Lumos Pharma Inc	49.69 %
Abiomed Inc	45.51 %
Vaso Corporation	44.99 %
Corbus Pharmaceuticals Holdings Inc	44.33 %
Catalent Inc	44.18 %
3m Company	37.97 %
Enanta Pharmaceuticals Inc	37.74 %
National Healthcare Corp	37.41 %
Pacific Health Care Organization Inc	36.99 %
China Biologic Products Holdings Inc	36.14 %

Date modified: 2026-09-18T13:11:02+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.